Article Details

Morgan Stanley likes biopharma as a defensive play — giving one stock 119% upside

Retrieved on: 2024-01-22 00:18:37

Tags for this article:

Click the tags to see associated articles and topics

Morgan Stanley likes biopharma as a defensive play — giving one stock 119% upside. View article details on hiswai:

Excerpt

The sector offers a safe haven from macroeconomic and earnings concerns ahead of quarterly results from European companies, according to the Wall ...

Article found on: www.cnbc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo